Bellevue Group »

Crispr Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $56M 900k 62.60
2023-09-30 $41M 898k 45.39
2023-06-30 $51M 899k 56.14
2023-03-31 $41M 900k 45.23
2022-12-31 $37M 912k 40.65
2022-09-30 $61M 928k 65.35
2022-06-30 $56M 922k 60.78
2022-03-31 $58M 927k 62.78
2021-12-31 $74M 975k 75.78
2021-09-30 $109M 975k 111.91
2021-06-30 $157M 967k 161.91
2021-03-31 $119M 978k 121.82
2020-12-31 $139M 910k 153.07
2020-09-30 $79M 949k 83.64
2020-06-30 $59M 801k 73.49
2020-03-31 $34M 801k 42.41
2019-12-31 $45M 731k 60.91
2019-09-30 $34M 837k 40.97
2019-06-30 $38M 811k 47.10